Holdings
32
Concentrated
Top 10 weight
61%
Concentration
Active share
-
Style
Equity
97%
Asset allocation
Portfolio
-Sectors
7High-conviction bets
-Top sector wt.
0.0%Cash
Market-cap allocation
Large cap34%
Mid cap18%
Small cap45%
Asset allocation
Equity97%
Top holdings
10.9%
Divi's Laboratories Ltd.EQUITY
9.1%Cipla LimitedEQUITY
8.4%8.2%
8.1%
TREPS / Reverse Repo InvestmentsCASH_EQUIVALENT
7.6%Illumina IncEQUITY
7.6%6.9%
Gland Pharma LimitedEQUITY
6.5%6.5%
Aster DM Healthcare Ltd.EQUITY
6.4%6.4%
Globus Medical IncEQUITY
5.7%Ajanta Pharma Ltd.EQUITY
5.6%Mankind Pharma Ltd.EQUITY
5.2%4.8%
4.1%
4.1%
Rubicon Research Ltd.EQUITY
4.0%3.6%
3.4%
3.2%
Clearing Corporation of India Ltd.CASH_EQUIVALENT
3.2%Dr. Lal Path Labs Ltd.EQUITY
3.1%3.1%
2.9%
2.6%
2.6%
Sai Life Sciences LtdEQUITY
2.6%2.6%
Cipla Ltd.EQUITY
2.6%Abbott India Ltd.EQUITY
2.6%Pfizer LimitedEQUITY
2.5%Indoco Remedies LimitedEQUITY
2.2%2.1%
Anthem Biosciences Ltd.EQUITY
2.1%Intuitive Surgical IncEQUITY
2.0%Global Health Ltd.EQUITY
1.9%Concord Biotech LimitedEQUITY
1.8%Pfizer Ltd.EQUITY
1.7%1.5%
Zydus Lifesciences Ltd.EQUITY
1.4%Fortis Healthcare Ltd.EQUITY
1.4%1.4%
Lupin Ltd.EQUITY
1.3%1.2%
1.0%
1.0%
AI Smart summary
Pros
- Balanced across the metrics we track.
Cons
- High top-10 concentration (61%).
- Small-cap heavy (45%) - higher volatility.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in this category.
No peers found in this category.
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
125.9%
48.9%
7.9%
3.1%
2.2%
0.9%
0.7%
0.5%